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A B S T R A C T
Three years long, prospective study was performed in order to evaluate a possible influence of continuing medical ed-
ucation of general practitioners on managing the patients with common diseases such as iron deficiency anemia (IDA).
Altogether 1586 patients that were referred to Hematology Outpatient Clinic, University Hospital Center Rijeka, Croatia
due to diagnosis of IDA were examined by clinical hematologist during the first visit and follow up period, were ques-
tioned by the means of questionnaire and complete laboratory analyzes were performed in order to: evaluate physical con-
dition and laboratory findings, to assess duration of anemia, possible other specialists’ consultation, iron supplemen-
tation therapy, and finally, determine the type of anemia present. Initial group of 983 patients was examined during one
year period. Following the education campaign the same parameters were analyzed in comparable (final) group of 603
patients during next one year period. Following the education, the number of patients referred to Outpatient Clinic due to
diagnosis of IDA was significantly decreased from 983 (61.97%) to 603 (38.02%) (p<0.05) as was the number of patients
referred as having IDA but finally established to have a different type of anemia, from 661 (97.24%) to 149 (24.71%)
(p<0.001). The number of patients started on iron supplementation therapy before establishing the type of anemia was
significantly decreased from 543 (55.24%) to 76 (12.60%) (p<0.001) as well as duration of iron supplementation therapy
administered in these cases (21±9.8 vs. 6±8.7 weeks) (p<0.001). We have detected a significant decrease in: time neces-
sary for definitive diagnosis (49±19.2 vs. 28±9.1 weeks) (p<0.001), number of visits to other specialists (2.9±1.35 vs.
1.1±0.94) (p<0.05), duration of anemia before treatment initialization (41±29.8 vs. 26±18.7 weeks) (p<0.001). Average
hemoglobin (Hg) level in patients referred to hematologist was significantly lower following education (98.9±15.5 vs.
82.6±14.2) (p<0.05). Continuing medical education of primary care physicians has significant role in diagnosis and
treatment of patients with IDA. Education programs result in benefits for the patients and physicians.
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Introduction
Iron deficiency anemia (IDA) is the most common
form of anemia occurring in about 20% of women, 50% of
pregnant women and 2–3% of men1,2. Iron deficiency re-
sults when iron demand by the body is not met by iron
absorption from diet. Thus, IDA in patients presenting in
primary care may result from inadequate dietary intake,
impaired absorption or physiologic losses in a women of
reproductive age. It also could result from occult blood
loss1,2. Generally, IDA is not an end diagnosis, and re-
quires complete work-up until the underlying cause is
not discovered.
IDA is classically described as a microcytic anemia
and differential diagnosis includes iron deficiency, tha-
lassemia, sideroblastic anemias, some types of anemia of
chronic disease, and lead poisoning2. Sideroblastic ane-
mia could be easily distinguished due to almost complete
saturation of the serum transferrin2 while patients with
lead poisoning display other symptoms resulting from
lead accumulation. Differentiating between IDA and ane-
mia of chronic disease could sometimes be difficult, espe-
cially when the two conditions coexist or in early iron de-
ficiency.
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The symptoms of anemia, such as dyspnea, weakness,
tachycardia, depression, and most especially fatigue, can
lead to a substantial reduction in functional ability and a
decline in general health contributing to patient’s feel-
ings of diminished quality of life (QOL). IDA has been
suggested to influence cognitive functions3 and correc-
tion of anemia resulted in improvement of cognitive abili-
ties. The level of improvement in cognitive functions de-
pended on duration of anemia emphasizing the impor-
tance of early recognition and the treatment of iron defi-
ciency anemia4–6.
IDA cannot be reliably diagnosed by clinical presenta-
tion and due to variable symptoms and these patients are
often referred to different specialists. The most common
reason to check hemoglobin in a primary care practice is
fatigue7. The diagnosis of IDA requires laboratory confir-
mation of anemia and evidence of iron deficiency and can
easily be established in most patients seen by their gen-
eral practitioner using laboratory tests available to them.
Previous studies have shown that continuing medical
education in a primary care practice could improve the
outcomes of care delivery8,9. This prospective study was
undertaken in order to analyze a possible influence of
continuing medical education of general practitioners on
managing the patients with common diseases such as
IDA by analyzing: information obtained through detail
anamnesis, clinical and laboratory findings in patients
referred to hematologist with diagnosis of IDA. Complete
laboratory and, if necessary, diagnostic work-up has been
performed in patients referred as having IDA in order to
determine a type of anemia present and possible under-
lining illness.
Materials and Methods
Patients
Altogether 1586 patients, 294 (18.54%) men and 1292
(81.46%) women, referred to Hematology Outpatient Cli-
nic, University Hospital Center Rijeka, Rijeka, by their
general practitioners as having IDA (irrespective of whe-
ther they really did have IDA, or were diagnosed previ-
ously or not by their general practitioner) were included
in this three years prospective study during the period
2003–2006. All referred patients were examined by clini-
cian hematologist during the first visit and follow up pe-
riod, were questioned by the means of questionnaire and
a complete laboratory analyzes were performed in order:
to evaluate physical condition and laboratory findings, to
assess duration of anemia, possible other specialists’ con-
sultation due to different symptoms, iron supplemen-
tation therapy, and finally to determine the type of ane-
mia present, IDA or other. In all patients necessary, a
complete diagnostic work-up was completed in order to
confirm or exclude an underlining illness.
In the first step initial group of 983 patients (»initial
group«) was examined during one year period. In the sec-
ond step, during a one year period, the education cam-
paign regarding the diagnosis and management of IDA
has been undertaken. Project staff used publications, lec-
tures and anemia management guidelines directed to
improve the knowledge about symptoms and signs of
anemia, possible mechanisms, morphological classifica-
tion of anemia, diagnostic and therapeutic approach, be-
tween primary care physicians. In the third step, follow-
ing the education project, the same parameters were
analyzed, in a comparable group of 603 patients (»final
group«) visiting our Outpatient Clinic during the next
one year period.
Complete laboratory analyzes of blood samples from
all examined patients were undertaken including: iron
level, unsaturated iron-binding capacity (UIBC), total
iron-binding capacity (TIBC), hemoglobin level (Hg), fe-
rritin level, transferrin saturation (TSAT), red blood cell
count (RBC), mean corpuscular volume (MCV), mean
corpuscular hemoglobin concentration (MCHC), white
blood cell count (WBC), platelets number. Laboratory
analyses performed by general practitioners before and
following the education project were compared to deter-
mine the possible differences in execution of diagnostic
algorithm for IDA in general practice.
Statistics
The differences in age and sex were analyzed by
one-way ANOVA and c2-test, respectively. The inter-
-group differences between pre-education (initial group)
and after-education (final group) questionnaire results
were analyzed using the c2-test. All statistical analyses
were performed using Statistica for Windows (release
6.1, StaSoft. Inc. Tulsa, OK, USA). The level of statistical
significance was set at 0.05.
Results
There was a significant difference in sex distribution
of examined patients (c2=0.49; p<0.001) with predomi-
nance of female patients. Average age of the patients was
45.15 years (range 21–81 years) in females, and 67.87
years (range 50–83 years) in males. The female patients
were significantly younger as compared to male patients
(p<0.001).
Following undertaken education the number of pa-
tients visiting Outpatient Clinic due to diagnosis of IDA
was significantly decreased as compared to the same pe-
riod of time before the education from 983 (61.97%) to
603 (38.02%) patients (p<0.05).
Out of 1586 patients referred to Hematology Outpa-
tient Clinic, Rijeka University Hospital Center, initial di-
agnosis of IDA has been confirmed in only 776 (48.93%)
patients, while other types of anemia were established in
altogether 810 (51.07%) patients, as shown in Table 1.
Following the education number of patients referred as
having IDA but finally established to have a different
type of anemia was significantly decreased from 661
(67.24%) patients to 149 (24.71%) patients (p<0.001).
Following the education the number of patients star-
ted on iron supplementation therapy before establishing
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the type of anemia, IDA or other, was significantly de-
creased as compared to the same period of time before
the education from 543 (55.24%) to 76 (12.60%) patients
(p<0.001). Also, duration of iron supplementation ther-
apy administered in other types of anemia or before con-
firmation of IDA as a final diagnosis was significantly de-
creased following the education as compared to the same
period of time before the education from 21±9.8 weeks to
6±8.7 weeks (p<0.001).
Out of 1586 patients only 89.29 (5.63%) patients have
had an underlining hematological illness. Since, IDA is,
generally, not a final diagnosis other patients were, dur-
ing the diagnostic process, diagnosed for other under-
lined illnesses. In examined patients underlining dis-
eases were most commonly detected in gastrointestinal
system in 948 (59.77%) patients, followed by gyneco-
logical diagnosis in 507 (31.9%) patients, previously men-
tioned hematological illnesses, diseases of immune sys-
tem in 27 (1.70%) patients, and diseases of respiratory
system in 5 (0.31%) patients, while in 8 (0.50%) cases no
underlining cause have been determined.
Statistically significant results of performed question-
naire in initial and final patient groups as well as statisti-
cal analyses regarding duration of IDA, time necessary
for determining a definitive diagnosis of anemia type and
initialization of treatment as well as number of other
specialists’ consultation were summarized and shown in
Table 2. Comparison between execution of laboratory
analyses in general practice before and following the edu-
cation was summarized and shown in Table 3. Obtained
values of performed laboratory analyses in general prac-
tice and outpatient clinic were shown in Table 4. The dif-
ferences between laboratory results obtained in primary
care practice and outpatient clinic were, probably, due to
different number of patients examined, since only in
Clinical Hospital a complete laboratory workup of blood
samples of all examined patients was performed, as well
as the differences in laboratory equipment used.
Discussion
According to our knowledge, this is the first study
evaluating the significance of continuous medical educa-
tion of general practitioners about IDA by assessing the
possible changes and improvements in managing these
patients in general practice through patient follow-up,
analyzes of anamnesis information, clinical and labora-
tory finding in patients referred to hematologists as hav-
ing IDA. The results of this study clearly show that conti-
nuingmedical education of general practitioners improves
management of patients with common diseases such as
IDA in their general practice. In contrast to this study,
based on evaluating changes in clinical practice, most of
the studies evaluating the influence of continuous medi-
cal education assess the improvement and obtained theo-
retical as well as practical knowledge through different
testing methods of target trainee groups before and/or
following the education program. At this point we should
stress out that the aim of this study was not to analyze
the reasons for referrals. Besides adequate reasons for
referral such as inability of general practitioner to estab-
lish the diagnosis, treatment failure and the need for
transfusion, we suspect that some patients were referred
for inadequate reasons, due to patient persistence for un-
necessary referral, inadequate treatment or insufficient
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TABLE 1
TYPE OF ANEMIA ESTABLISHED IN PATIENTS REFERRED DUE TO DIAGNOSIS OF IRON DEFICIENCY ANEMIA
Type of anemia
All patients
N (%)
Initial group
N (%)
Final group
N (%)
Referred patients 1586 (100) 983 (100) 603 (100)
Iron deficiency anemia 776 (48.93) 322 (32.76) 454 (75.29)
Anemia of chronic disease 705 (44.45) 570 (57.98) 135 (22.38)
Megaloblastic/macrocytic 24 (1.51) 18 (1.83) 6 (1.00)
Anemia of multiple mechanisms/other type of anemia 81 (5.11) 73 (7.42) 8 (1.32)
TABLE 2
RESULTS OF QUESTIONNAIRE REGARDING DURATION AND CONFIRMATION OF IRON DEFICIENCY ANEMIA
AND SPECIALIST CONSULTATIONS
Clinical questions
Initial group
X±SD
Final group
X±SD
p-value*
Duration of anemia before treatment (weeks) 41±29.8 26±18.7 p<0.001
Number of visits to other specialists per patient 2.9±1.35 1.1±0.94 p<0.05
Hemoglobin (Hg) level before referral to hematologist 98.9±15.5 82.6±14.2 p<0.05
Time necessary for definitive diagnosis and treatment (weeks) 49±19.2 28±9.1 p<0.001
*c2-test – p<0.05 was considered significant
knowledge or/and involvement of general practitioner to
manage the patient.
The most commonly used definitions of anemia are
suggested by the Centers for disease Control and Preven-
tion and the World Health Organization (WHO). The di-
agnosis of IDA requires that a patient be anemic and
show laboratory evidence of iron deficiency. Still, initial
diagnosis of IDA was very often considered by primary
care physicians in cases of iron deficiency with no real ev-
idence of anemia or in other types of anemia, especially
before the education project.
The serum ferritin level is considered the most accu-
rate initial diagnostic test for IDA, reflecting iron storage
and absolute iron deficiency, but we have found that it is
rarely performed by primary care physicians before pa-
tient referral to hematologist. Following the education
program this diagnostic test was performed significantly
more commonly in general practice (0.9% vs. 60%). Fe-
rritin level, as determined during the diagnostic proce-
dures, was decreased in majority of referred patients. In
patents with IDA the amount of iron available to bind to
the iron-caring protein transferrin is reduced, causing a
decrease in the transferrin saturation (TSAT) and an in-
crease in the unsaturated iron-binding capacity (UIBC).
Absolute iron deficiency is defined by TSAT<20% or se-
rum ferritin <10 mg/L10–12.
Although, TSAT and serum ferritin have been sug-
gested as simple and favorable markers for assessment of
iron status due to their widespread availability, extensive
literature base, and familiarity12–15, TSAT values were
not determined during laboratory analyzes undertaken
in general practice before, but also after the education of
general practitioners.
It is clear that diagnostic procedure for IDA could eas-
ily be made in most patients seen by their general practi-
tioners using laboratory tests available to them. But, es-
pecially before education, laboratory analyzes performed
in a primary care practice in patients referred to hema-
tologist as having IDA were, often, inadequate to clearly
confirm this diagnosis or, in some cases, blood analyses
were not performed at all before referral. Thus, incom-
plete diagnostic procedures could lead to unnecessary
iron supplementation therapy usage and administration
of oral iron supplement therapy before confirmation of
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TABLE 3
EXECUTION OF DIAGNOSTIC ALGORITHM BY GENERAL
PRACTITIONERS IN PATIETS REFERRED DUE TO DIAGNOSIS
OF IRON DEFICIENCY ANEMIA
Laboratory
analyzes
Initial group
(N=983)
Final group
(N=603) p-value*
N† (%) N† (%)
Fe 671 (68.26) 586 (97.18) p<0.05
UIBC 532 (64.12) 520 (86.23) p<0.05
TIBC 510 (51.88) 516 (85.57) p<0.01
Hg 906 (92.17) 603 (100.0) p>0.05
Ferritin 9 (0.92) 374 (62.02) p<0.001
TSAT ND ND ND
RBC 925 (94.09) 603 (100.0) p>0.05
MCV 683 (69.48) 540 (89.55) p<0.05
MCHC 558 (56.76) 476 (78.94) p<0.01
WBC 827 (84.13) 574 (95.19) p<0.05
PLT 790 (80.36) 552 (91.54) p<0.05
*c2-test – p<0.05 was considered significant; N† – patients with
laboratory analyzes, ND – not done
TABLE 4
VALUES OF LABORATORY ANALYZES OBTAINED IN GENERAL PRACTICE AND CLINICAL HOSPITAL
Laboratory analyzes
Initial group (N=983) Final group (N=603)
General practice Hospital General practice Hospital
X±SD X±SD X±SD X±SD
Fe (mmol/L) 8.4±4.8 6.8±3.2 5.9±3.7 5.5±3.4
UIBC (mmol/L) 59.1±14.6 64.2±15.1 64.1±6.2 66.2±9.1
TIBC (mmol/L) 77.9±16.3 82.3±10.3 81.9±12.5 84.3±10.3
Hg (g/L) 98.9±15.5 91.6±12.4 82.6±14.2 81.0±12.4
Ferritin (mmol/L) ND 19.7±16.9 6.8±14.1 13.7±18.9
TSAT (%) ND 24±13.1 ND 18±8.6
RBC (x1012/L 3.1±0.8 2.9±1.4 3.0±1.3 2.7±0.9
MCV (fL) 78.9±11.3 65.9±16.3 78.9±11.3 65.9±16.3
MCHC (g/L) 318.6±15.5 271.6±19.7 311.6±16.1 283.6±14.7
WBC (x109/L) 6.4±1.9 6.2±2.1 6.7±2.1 6.4±2.5
PLT (x109/L) 198.9±45.5 182.0±37.9 185.9±32.8 187.0±39.8
ND – not done
IDA, in cases with no real evidence of iron deficiency
present or in other types of anemia.
The majority of general practitioners were not famil-
iar with a diagnostic algorithm of IDA and their knowl-
edge was significantly improved following education pro-
ject, resulting in improved management of patients with
IDA and increased usage of generally suggested diagnos-
tic algorithm. Standard laboratory analyzes for assess-
ment of IDA were more commonly performed in general
practice including: serum iron, Hb and ferritin level,
UIBC, TIBC, RBC, MCV, and MCHC, resulting in shorter
period of time necessary to determine a type of anemia
present. Following confirmation of IDA a therapeutic
trial of oral iron supplement therapy is one of the recom-
mended initial approaches16.
The symptoms of anemia, especially fatigue, weak-
ness, impaired cognitive function, and even depression,
can lead to a substantial reduction in functional ability
and diminished QOL in affected patients, even in cases of
mild and moderate anemia (Hb levels of 10–12 g/dl and
8–10 g/dl, respectively)4,6,17. The problem is more signifi-
cant if the symptoms persist for a long period of time.
Following the education project the average duration of
anemia as well as the number of other specialist’s consul-
tations was significantly reduced. The final diagnosis
and therapy initiation were achieved in significantly
shorter time period resulting in faster improvement in
patient’s general health, functional ability and QOL.
Although, initiation of iron supplementation therapy
is important in order to reduce symptoms of anemia in
patients with IDA, we cannot forget that IDA should
never be considered an end diagnosis. It has physiologic
and pathophysiologic causes, so the work-up is not com-
plete until the underlining reason is known or serious
disease might be overlooked. As in our study, previous
studies have labeled diseases of gastrointestinal system
as the most common underlining cause of IDA16,18–21. The
diagnostic strategy and generally suggested evaluation
for underlying cause of IDA that should be indicated ac-
cording to patient’s age7,16,19,21,22 has not been completed
in general practice. Generally, patients suspected to have
IDA, other type of anemia or symptoms resulting from
anemia, were directed to different specialist depending
on the symptoms present, an average number of special-
ist consultation being significantly higher (three differ-
ent specialist) before the education project (one specialist
consultation). We presume, that following the education
of general practitioners their knowledge about managing
the patients with anemia and generally suggested evalu-
ation for underlying cause of IDA was improved resulting
in better management of these patients through directed
work-up according to patients age and symptoms leading
to decrease in the number of different specialist consul-
tations and shorter diagnostic period.
In conclusion, continuing medical education of gen-
eral practitioners as well as clinicians of other specialties
has significant role in establishing an early diagnosis and
treatment of patients with IDA. Education programs re-
sult in benefits for the patients and physicians. Most sig-
nificantly the continuing medical education could im-
prove QOL in patients with IDA due to more commonly
applied diagnostic algorithm of IDA in a general practice,
shorter diagnostic period, less specialist consultations
and less hospitalization days. Also, we presume that
these programs could reduce government expenses for
medical care in these patients.
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ULOGA KONTINUIRANE MEDICINSKE EDUKACIJE LIJE^NIKA PRIMARNE ZDRAVSTVENE
ZA[TITE O U^ESTALIM BOLESTIMA – SIDEROPENI^NA ANEMIJA
S A @ E T A K
Prospektivna, trogodi{nja studija provedena je s ciljem utvr|ivanja utjecaja kontinuirane medicinske edukacije lije-
~nika primarne zdravstvene za{tite na kvalitetu lije~enja bolesnika s u~estalim bolestima kao {to je sideropeni~na ane-
mija. Ukupno 1586 bolesnika upu}enih u ambulantu za hematologiju, KBC Rijeka, s uputnom dijagnozom sideropeni~ne
anemije pregledao je hematolog tijekom prvog pregleda i perioda pra}enja. Svi su bolesnici ispitani pomo}u upitnika, te
je u~injena kompletna laboratorijska analiza kako bi se: evaluirao fizikalni status bolesnika i laboratorijski nalazi,
utvrdilo trajanje anemije, broj pregleda drugih specijalista radi simptoma anemije, primjena terapije preparatima `e-
ljeza i odredio tip anemije. U inicijalnoj skupini ispitano je 983 bolesnika upu}enih u hematolo{ku ambulantu tijekom
godine dana. Nakon provedene edukacijske kampanje isti parametri analizirani su tijekom naredne godine u 603 bole-
snika zavr{ne skupine. Nakon provedene edukacije broj bolesnika upu}enih u ambulantu za hematologiju pod uputnom
dijagnozom sideropeni~ne anemije bio je zna~ajno sni`en, sa 983 (61,97%) na 603 (38,02%) bolesnika (p<0,05), kao i
broj bolesnika u kojih je utvr|en drugi oblik anemije, sa 661 (97,24%) na 149 (24,71%) (p<0,001). Broj bolesnika u kojih
je primijenjena terapija preparatima `eljeza prije utvr|ivanja oblika anemije bio je zna~ajno sni`en nakon provedene
edukacije sa 543 (55,24%) na 76 (12,60%) bolesnika (p<0,001), kao i trajanje terapije preparatima `eljeza u ovih bo-
lesnika (21±9,8 vs. 6±8,7 tjedana) (p<0,001). Utvrdili smo zna~ajno sni`enje: vremena potrebnog za utvr|ivanje kona-
~ne dijagnoze (49±19,2 vs. 28±9,1 tjedana) (p<0,001), broja specijalisti~kih pregleda (2,9±1,35 vs. 1,1±0,94) (p<0,05),
trajanja anemije prije uvo|enja terapije (41±29,8 vs. 26±18,7 tjedana) (p<0,01). Vrijednost hemoglobina (Hg) u bo-
lesnika upu}enih hematologu bila je zna~ajno ni`a nakon edukacije (98,9±15,5 vs. 82,6±14,2) (p<0,05). Kontinuirana
medicinska edukacija lije~nika primarne zdravstvene za{tite ima va`nu ulogu u dijagnostici i lije~enju bolesnika sa
sideropeni~nom anemijom. Edukacijski su programi od koristi i bolesnicima i lije~nicima.
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